Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Dimethyl fumarat - a new player in oral treatment options for relapsing forms of multiple sclerosis.
Group specific vein-atlasing: An application for analyzing the venous system under normal and multiple sclerosis conditions.
Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Emerging injectable therapies for multiple sclerosis.
[Targeted Therapy and Progressive Multifocal Leukoencephalopathy (PML): PML in the Era of Monoclonal Antibody Therapies].
Brain Perfusion and Vasoreactivity in Multiple Sclerosis.
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis.
Management of neurogenic bladder in patients with multiple sclerosis.
Aging with multiple sclerosis: cognitive, emotional and neuropathological considerations.
Seasonality of 278 neuromyelitis optica relapses in a Brazilian cohort.
[Pathology of the Peripheral Nervous System in Guillain-Barré Syndrome].
Label free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
Spatial Analysis of Multiple Sclerosis Disease in Tehran Metropolitan Zone, Iran, 2001-2012.
Medical, functional, and legal aspects of vocational rehabilitation for people with multiple sclerosis.
Pain in acquired inflammatory demyelinating polyneuropathies.
Aquaporin-4: A novel diagnostic biomarker for seronegative neuromyelitis optica.
Does ability to walk reflect general functionality in inflammatory neuropathies?
Current and Future Therapies for Multiple Sclerosis.
Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.
Pertussis toxin attenuates experimental autoimmune encephalomyelitis by upregulating neuronal vascular endothelial growth factor.
Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination.
Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions.
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom.
Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features.
Pages
« first
‹ previous
…
614
615
616
617
618
619
620
621
622
…
next ›
last »